glp-1 for ckd GLP1 Receptor Agonists vs SGLT2-I in Preventing in T2DM: An Interview – AJKD Blog The expanding benefits of GLP-1
Description
2) and treating various diseases [42]
Areas covered Resources were extracted from the PubMed database, using keywords such as glucagon-like peptide-1, GLP-1 RA, SARS-CoV-2, COVID-19, inflammation, in April2021
Other companies are still playing catch-up
This is still early-stage science, but the mechanistic rationale is building
10.1016/j.neuropharm.2011.12.022 34 KlausenM
